International plasma
protein congress (IPPC)

TIME (GMT+1)
‍
07:30 - 17:30
On-site registration open
‍
09:00 - 09:15
Welcome & Opening Ceremony‍
Anita Brikman, President and CEO - PPTA

Video Message
Adam Jarubas, Ph.D., Member of the European Parliament, Chair of the Committee on Public Health (SANT)

09:15 - 10:00
Plenary Session: Trade & Tariffs: Trump 2.0 and Its Effect on the Plasma Industry: A Discussion of Key Issues
Paul Rosenthal, a leading Washington D.C.-based international trade lawyer, joins PPTA’s VP of Government Affairs, Sharon Pearce, and Senior Director, Global Plasma & International Affairs, Julia Fabens, to provide an overview of the first 100 days of the Trump Administration, and how its moves on tariffs, trade, border security, regulatory authority, and other policy issues may impact Europe and the PDMP industry.
‍
Speakers:
Paul Rosenthal, Trade Expert - Kelley Drye & Warren LLP

Sharon Pearce, Vice President, Government Affairs - PPTA

Julia Fabens, Senior Director, Global Plasma and International Affairs - PPTA

10:00 - 10:45
SESSION 1: Patient-Driven Progress: Advancing Plasma-Derived Medicines & Addressing Disparities
‍Patients and patient advocates discuss the last two decades of progress in disease diagnosis, patient access to plasma-derived medicinal products (PDMPs), policy, and more. Kick off IPPC with a look at the past, present, and future of patient need.

Moderator: Sarah-Taïssir Bencharif, M.D., Freelance Health Journalist, Event Moderator, and Emergency Physician

Speakers:
Matine Pergent, President - International Patient Organisation for Primary Immunodeficiencies (IPOPI)

(VIRTUAL) Fernanda Aspilche Ferro, President - Alpha-1 Europe

Nancy Di Salvo, International Affairs Director - GBS/CIDP Foundation International

Nathan Schaefer, Public Policy - World Federation of Hemophilia

10:45 - 11:30
Networking Break

11:30 - 12:45
SESSION 2: Critical Medicines: European Strategies for Preventing Shortages and Securing Supply
Dive into the European Union’s latest efforts to strengthen medical supply chains, prevent disruptions, and improve the resilience of health care systems during emergencies. Experts will unpack key initiatives such as the Pharmaceutical Legislation, the Critical Medicines Act, and the European Shortages Monitoring Platform (ESMP). Find out what is new and changing in this area and why it matters for plasma-derived medicines. 

Moderator:  Vasiliki Angouridi, Health Editor - Euractiv

Speakers:
Sandra Dang, Medicines and Medical Devices Shortages Officer - European Medicines Agency

Steffen Mager, Vice President of Biopharma Sales & Commercial Operations Europe - Grifols

Leire Solis, Director for Health Policy and Advocacy - International Patient Organisation for Primary Immunodeficiencies (IPOPI)

(VIRTUAL) Stefaan Van der Spiegel, Head of Sector - Substances of Human Origin (SoHO - blood, tissues, cells, organs) - European Commission

12:45 - 14:00
Networking Lunch

14:00 - 15:15
SESSION 3: Pushing Barriers: Global Perspectives on Improving Patient Access
Examine the global landscape of patient access to plasma-derived medicines. Understand the challenges that limit access for patients outside of Europe and the U.S., and discover the innovative solutions being used in diverse regions of the world.

Moderator: Svenja Barckhausen, CEO and Founder - Blood Plasma Strategy Experts UG

Speakers: 
Dana Miloslavich, Director of Research - Marketing Research Bureau

Juçaíra Stella M Giusti, Associação Eu Luto Pela Imuno Brasil- ELPIB
‍
Nariman Sadri, CEO - Darman Ara Co.

Tineke Zurrbier, Public Affairs and Advocacy Lead, Plasma Derived Therapies - Takeda

Dr. Amin Magdy, CEO - Grifols Egypt

15:15 - 16:00
Networking Break

16:00 - 17:15
SESSION 4: Innovation: What’s Next for PDMPs?
Discover the latest innovations in research and development of plasma-derived medicines. Attendees will learn about the industry’s ongoing work to develop novel therapies, and explore new, evidence-based indications for already approved therapies.

Moderator: John Curling, Independent Consultant - JCC AB

Speakers:
Joerg Schuettrumpf, Chief Scientific Innovation Officer - Grifols

Rudolf Hartmann, Head of PDT Analytical Development - Takeda

Andrea Denardo, Specialist, Research and Innovation - Kedrion

17:15 - 17:30
End of the Day Closure and Presentation of the Hilfenhaus Award
Presented by: Ferdinando Borgese, Vice President Intercontinental Region & ICM - Kedrion Biopharma and Chair of PPTA Europe

17:30 - 19:30
Networking Reception in the Exhibit Hall/Foyer - Sponsored by ImmunoTek Bio Centers

TIME (GMT+2)
‍
08:00 - 15:00
On-site registration open
‍
08:30 - 08:45
Day Two Kickoff and Welcome

08:45 - 09:30
Leadership Perspectives: Navigating an Evolving Industry & World
‍Join PPTA President and CEO Anita Brikman for an intimate conversation with industry leaders. Senior executives from Grifols, Kedrion, and Takeda will share lessons learned on leadership, growth, resilience, and innovation.

Moderator: Anita Brikman, President & CEO - PPTA

Speakers:
Ugo Di Francesco, Chief Executive Officer - Kedrion
‍
David Bell, Chief Corporate Affairs and Legal Officer - Grifols

Margaret Drysdale, PDT Regional Commercial Strategy Head - Takeda
‍
09:30 - 10:45
SESSION 5: Methodologies in Donor Health and Safety Research
Learn about how ongoing research is contributing to future improvements in plasma donor safety. This session will offer an overview of using real world data to produce real world evidence in research surrounding global donor health and safety.

Moderator: Lise Estcourt, M.D., Medical Director for Transfusion - NHS Blood and Transplant (NHSBT); Medical Director of NHSBT Clinical Trials Unit - NHSBT

Speakers: 
(VIRTUAL) Juan Jose Abellan-Andres, Ph.D., Biostatistics and RWE Senior Specialist, Data Analytics and Methods Task Force - European Medicines Agency

Eva Hellman, Director Clinical Affairs - Haemonetics

Michelle Fransen, MPH, Director, Study Management - PPTA

10:45 - 11:00
Special Segment: "It's my Movie Time" - Hear from a Plasma Donor
Pauline Meßner, a plasma donor in Germany, takes the stage with Britta Diebel of Haema to share what inspired her to donate in the first place, why she finds donation meaningful, and how she shares plasma donation with her community. Plus, as a fan of visual media, Pauline will share her latest film & TV recommendations, as watching a show or a movie while donating is her favorite way to pass the time!

Speakers: 
Pauline Meßner - Plasma donor

Britta Diebel, Manager Communications Plasma Europe - Haema GmbH
‍
11:00 - 11:30
Networking Break

11:30 - 12:45
SESSION 6: Building a Resilient Supply of Plasma for Fractionation
Hear lessons learned around building a resilient global plasma supply chain that meets growing patient demand. Experts will address key issues such as the value of public-private coexistence and leveraging the implementation of the Substances of Human Origin (SoHO) legislation. This discussion includes a variety of innovative practices that model a sustainable and resilient supply chain.

Moderator: Brad Pick, Senior Director Global External Communications - Grifols

Speakers:
(VIRTUAL) Stefaan Van der Spiegel, Head of Sector - Substances of Human Origin (SoHO - blood, tissues, cells, organs) - European Commission
‍
Milan Maly, Chairman - European Plasma Alliance

Jean-Philippe Plançon, President - EPODIN

Mag. Dr. Karmin Saadat, Department Good Manufacturing Practice - Austrian Agency for Health and Food Safety (AGES)

Lorenzo Montrasio, Advisor to the Italian Blood Centre & the Italian Presidency of Ministers for Health Literacy
‍
12:45 - 14:00
Networking Lunch
‍
14:00 - 15:15
SESSION 7: Ensuring Access: The Role of Market Policies for PDMPs - Role of National Medicines Policies
Explore market access policies surrounding plasma-derived medicines, such as mandatory stockpiling and restrictive reimbursement policies. Understand the impact of economic measures on plasma-derived medicines and the patients they benefit from. The session offers policy recommendations and discusses the necessity of shifting from “one-size-fits-all” policies to more patient-centric, tailored approaches.

Moderator: Tomasz Kluszczyński, Director - ACESO Healthcare Consulting

Speakers: 
Dr. Tobias Volkwein, Partner - D+B Lawyers

Jakub Dvořáček, Deputy Minister for Health Czech Republic
‍
Adrian Goretzki - Healthcare Education Institute (EDU) & Patient Advocate

Anna Kostera-Pruszczyk, Professor of Neurology & Pediatric Neurologist - Medical University of Warsaw

Natalia Bartosik, Global Value & Access Lead - Takeda
‍
15:15 - 15:30
Closure of IPPC 2025‍